This document is an excerpt from the EUR-Lex website
Document 62021TN0797
Case T-797/21: Action brought on 23 December 2021 — Gustopharma Consumer Health v EUIPO — Helixor Heilmittel (HELIXORIGINAL)
Case T-797/21: Action brought on 23 December 2021 — Gustopharma Consumer Health v EUIPO — Helixor Heilmittel (HELIXORIGINAL)
Case T-797/21: Action brought on 23 December 2021 — Gustopharma Consumer Health v EUIPO — Helixor Heilmittel (HELIXORIGINAL)
OJ C 73, 14.2.2022, p. 62–62
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
OJ C 73, 14.2.2022, p. 17–17
(GA)
|
14.2.2022 |
EN |
Official Journal of the European Union |
C 73/62 |
Action brought on 23 December 2021 — Gustopharma Consumer Health v EUIPO — Helixor Heilmittel (HELIXORIGINAL)
(Case T-797/21)
(2022/C 73/77)
Language of the case: English
Parties
Applicant: Gustopharma Consumer Health, SL (Madrid, Spain) (represented by: J. Wachinger and R. Drozdz, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Other party to the proceedings before the Board of Appeal: Helixor Heilmittel GmbH (Rosenfeld, Germany)
Details of the proceedings before EUIPO
Applicant of the trade mark at issue: Applicant before the General Court
Trade mark at issue: Application for European Union word mark HELIXORIGINAL — Application for registration No 17 234 824
Procedure before EUIPO: Opposition proceedings
Contested decision: Decision of the First Board of Appeal of EUIPO of 18 October 2021 in Case R 1644/2019-1
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO to pay the costs. |
Plea in law
|
— |
Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council. |